Learn About Septo-Optic Dysplasia

What is the definition of Septo-Optic Dysplasia?

Septo-optic dysplasia is a disorder that affects early brain development. This condition is typically defined as a combination of at least two of the following three features: underdevelopment (hypoplasia) of the nerves that carry visual information from the eye to the brain (optic nerves); abnormal development of the structures that separate the right and left halves (the midline) of the brain; and hypoplasia of the hormone-producing gland (pituitary gland) at the base of the brain. The signs and symptoms of septo-optic dysplasia can vary widely among affected individuals. Less than half of people with septo-optic dysplasia have all three of the main features.

What are the causes of Septo-Optic Dysplasia?

In most cases of septo-optic dysplasia, the cause of the disorder is unknown. Researchers suspect that a combination of genetic and environmental factors play a role in causing this disorder. Septo-optic dysplasia is more common in children born to young women who are pregnant for the first time. Children also have an increased risk of septo-optic dysplasia if they were exposed to alcohol or specific medications or drugs before birth, or if their mothers had certain viral infections while pregnant.  A disruption in blood flow to certain areas of the brain during critical periods of development may also increase the risk of septo-optic dysplasia.

How prevalent is Septo-Optic Dysplasia?

Septo-optic dysplasia affects approximately 1 in 10,000 newborns.

Is Septo-Optic Dysplasia an inherited disorder?

Septo-optic dysplasia is usually sporadic, which means that the condition typically occurs in people with no history of the disorder in their family.

Who are the top Septo-Optic Dysplasia Local Doctors?
Elite in Septo-Optic Dysplasia
Elite in Septo-Optic Dysplasia

Great Ormond Street Hospital

London, ENG, GB 

Mehul Dattani practices in London, United Kingdom. Mr. Dattani is rated as an Elite expert by MediFind in the treatment of Septo-Optic Dysplasia. His top areas of expertise are Hypopituitarism, Septo-Optic Dysplasia, Familial Hypopituitarism, Hormone Replacement Therapy (HRT), and Pancreatectomy.

Elite in Septo-Optic Dysplasia
Elite in Septo-Optic Dysplasia

UCL Great Ormond Street Institute Of Child Health

London, ENG, GB 

Louise Gregory practices in London, United Kingdom. Ms. Gregory is rated as an Elite expert by MediFind in the treatment of Septo-Optic Dysplasia. Her top areas of expertise are Familial Hypopituitarism, Hypopituitarism, Septo-Optic Dysplasia, and Cardiofaciocutaneous Syndrome.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Septo-Optic Dysplasia
Elite in Septo-Optic Dysplasia
384 Victoria Street, 
Darlinghurst, NSW, AU 

Mark Mccabe practices in Darlinghurst, Australia. Mr. Mccabe is rated as an Elite expert by MediFind in the treatment of Septo-Optic Dysplasia. His top areas of expertise are Septo-Optic Dysplasia, Hypopituitarism, Kallmann Syndrome, and Familial Hypopituitarism.

What are the latest Septo-Optic Dysplasia Clinical Trials?
A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients With Acquired Hypothalamic Obesity

Summary: This is a sub-study of Study RM-493-040 (NCT05774756). The goal of this sub-study is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years of age and older with congenital Hypothalamic Obesity (cHO). To determine how well setmelanotide works and how safe it is, patients with cHO will take a daily injection of either setmelanotide or plac...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Characterization of Sleep Features in Pediatric Patients With Septa-optic Dysplasia

Summary: The aim of this study is to evaluate sleep of patients with septo-optic dysplasia compared to patients with an isolated disorder of peripheral visual system and patients with corpus callosum agenesis since both visus defict and agenesis of corpus callosum might be present SOD but associated to other features / structural and functional anomalies. Included patients and their caregivers will be aske...

Who are the sources who wrote this article ?

Published Date: May 07, 2025
Published By: National Institutes of Health